pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp
ALMIRALL S.P.A
Almirall, S.A.
ALMIRALL S.P.A clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
- Employees
- 2
- Programs
- 11
- Drugs
- 20
- Patents
- 308
ALMIRALL S.P.A projects
11 ClinicalTrials.gov programs sponsored by ALMIRALL S.P.A.
ALMIRALL S.P.A has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
M-14867-33
Almirall, S.A.
Actinic Keratosis on the Face or Scalp
1 trial -
M-17923-34
Almirall, S.A.
Atopic Dermatitis
1 trial -
M-27501-30
Almirall, S.A.
Nummular Dermatitis
1 trial -
LAD328, SODIUM CHLORIDE
Almirall, S.A.
moderate-to-severe hidradenitis suppurativa
1 trial -
M-27134-10
Almirall, S.A.
Moderate-to-severe hidradenitis suppurativa
1 trial -
Placebo for LAD603, LAD603
Almirall, S.A.
Alopecia areata
1 trial -
M-27312-01
Almirall, S.A.
Inflammatory diseases
1 trial -
Almax Forte 1,5 g suspensión oral
Almirall, S.A.
heartburn and or reflux
1 trial -
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
Almirall, S.A.
Actinic Keratosis
1 trial -
Pidotimod
Almirall, S.A.
Recurrent Respiratory Tract Infections
1 trial -
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
How many clinical projects does ALMIRALL S.P.A have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.